arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

BioAtla, Inc.

BCAB

$3.42 ▲ +0.13 (+3.95%) at close

27 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

BioAtla, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $5.1M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 19.7% ↘

FCF / Share $-3.51

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-6.34M

↑ +58.6% —

FCF / Share Free cash flow per share

$-3.51

↓ -62617.3% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns

100

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
EPS Growth YoY (%)	-81053.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	46.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-22.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	27.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	45.8% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	46.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	68.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	41.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	17.2% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	11.1% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-1.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	2.6% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	—	-0.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	58.6% Excellent ↑ Excellent Improving Year-over-year change in net income	34.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-49.0% Weak ↓ Weak Declining Year-over-year change in net income	11.2% Fair ↓ Fair Declining Year-over-year change in net income	34.0% Excellent ↓ Excellent Declining Year-over-year change in net income	44.7% Excellent ↑ Excellent Improving Year-over-year change in net income	68.2% Excellent ↑ Excellent Improving Year-over-year change in net income	41.1% Excellent ↑ Excellent Improving Year-over-year change in net income	15.4% Good ↑ Good Improving Year-over-year change in net income	2.2% Caution ↑ Caution Improving Year-over-year change in net income	-29.3% Weak ↓ Weak Declining Year-over-year change in net income	-23.7% Weak ↓ Weak Declining Year-over-year change in net income	-13.2% Weak ↓ Weak Declining Year-over-year change in net income	-17.8% Weak ↓ Weak Declining Year-over-year change in net income	-12.4% Weak ↑ Weak Improving Year-over-year change in net income	4.9% Caution ↑ Caution Improving Year-over-year change in net income	-29.7% Weak ↑ Weak Improving Year-over-year change in net income	-42.7% Weak ↑ Weak Improving Year-over-year change in net income	-97.1% Weak ↑ Weak Improving Year-over-year change in net income	-388.3% Weak Weak Year-over-year change in net income	-1065.9% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	-62617.3% Weak Weak Year-over-year change in free cash flow	—	—	—	56.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-34.6% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
FCF / Net Income (x)	0.83x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.13x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	1.33x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.04x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.33x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	2.38x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Return on Invested Capital (%)	19.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	20.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	34.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	88.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-2543.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-90.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-55.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-31.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.5% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-14.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	8.5% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	5.6% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	1.5% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-108.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-66.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-86.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-68.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-46.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-23.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-13.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-6.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	17.0% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+13%)	27.0% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+80%)	50.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+237%)	111.7% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+645%)	—	-104.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-796%)	-46.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-407%)	-67.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-548%)	-46.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-412%)	-38.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-354%)	-35.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-335%)	-28.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-291%)	-17.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-217%)	-15.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-18.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-220%)	-17.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-217%)	-12.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-11.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-9.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-17.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-214%)	-9.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-7.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-152%)	15.6% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	9.7% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-35%)	2.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-81%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-30460.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-9398.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-8227.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-93.20x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-5.99x Weak Weak Operating income divided by interest expense Optimal: > 5x	-2.03x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-1.96M	$-7.12M	$-8.32M	$-18.21M	$-32.36M	$-49.05M	$-56.52M	$-61.66M	$-80.63M	$-111.47M	$-141.28M	$-168.69M	$-192.69M	$-215.51M	$-178.12M	$-202.29M	$-219.43M	$-244.98M	$-269.93M	$-207.61M	$-221.20M	$-238.60M	$-56.76M	$-184.00K	$-370.00K	$-3.70M	$-10.86M

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-4.22	$-0.00	$-0.01	$-0.01	$-0.01	$-0.01	$-0.00	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$-0.02	—	$-0.01	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-3.51	—	$-0.00	$-0.00	$-0.01	—	—	—	$-0.01	—	—	—	$-0.01	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-22.48	$-0.01	$-0.01	$-0.01	$0.00	$0.00	$0.01	$0.01	$0.02	$0.03	$0.04	$0.05	$0.07	$0.08	$0.08	$0.09	$0.11	$0.12	$0.13	$0.11	$0.12	$0.13	—	—	—	—	—
Tangible Book Value per Share (USD)	$-22.48	$-0.01	$-0.01	$-0.01	$0.00	$0.00	$0.01	$0.01	$0.02	$0.03	$0.04	$0.05	$0.07	$0.08	$0.08	$0.09	$0.11	$0.12	$0.13	$0.11	$0.12	$0.13	—	—	—	—	—
Basic Weighted Avg Shares (shares)	1.50M	—	2.94B	2.93B	2.91B	—	2.42B	2.41B	2.40B	—	2.39B	2.39B	2.38B	—	1.88B	1.87B	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Working Capital (USD)	$-17.60M	$-13.91M	$-8.31M	$4.01M	$21.53M	$36.69M	$41.10M	$49.03M	$67.17M	$88.06M	$111.91M	$141.65M	$173.46M	$197.30M	$159.48M	$181.69M	$206.83M	$227.48M	$228.29M	$176.18M	$194.05M	$208.42M	—	—	—	—	—
Total Equity (USD)	$-37.31M	$-36.19M	$-31.24M	$-16.75M	$547.00K	$14.27M	$22.97M	$31.37M	$49.72M	$70.67M	$94.70M	$124.52M	$156.43M	$180.34M	$142.63M	$164.95M	$190.05M	$210.82M	$230.65M	$178.02M	$195.92M	$209.97M	$-74.52M	$-63.84M	$-57.62M	$-56.01M	—

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	—	$0.00	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$120.00K	$19.00K	$56.00K	$115.00K	$183.00K	$228.00K	—	—	$240.00K	$368.00K	—	—	$293.00K	$298.00K	—	—	$313.00K	$314.00K	—	—	$309.00K	$292.00K	$285.00K	$215.00K	$216.00K	—	—
Net Income, GAAP (USD)	$-6.34M	$-9.78M	$-15.78M	$-18.71M	$-15.33M	$-14.88M	$-10.59M	$-21.07M	$-23.23M	$-26.93M	$-33.33M	$-35.75M	$-27.46M	$-27.54M	$-25.78M	$-28.91M	$-24.25M	$-23.39M	$-22.93M	$-30.38M	$-18.70M	$-16.39M	$-11.63M	$-6.22M	$-1.60M	—	—
Operating Cash Flow (USD)	$-5.27M	$-7.92M	$-9.88M	$-14.12M	$-16.29M	$-16.78M	—	—	$-30.83M	$-29.92M	—	—	$-22.65M	$-24.35M	—	—	$-25.14M	$-20.95M	—	—	$-14.99M	$-14.01M	$-15.46M	$-3.05M	$-3.81M	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 27 quarters

BioAtla, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BCAB with peers